M. İNANÇ Et Al. , "The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, pp.1878-1885, 2020
İNANÇ, M. Et Al. 2020. The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8 , 1878-1885.
İNANÇ, M., Sirakaya, H. A., Karaman, H., & BOZKURT, O., (2020). The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, 1878-1885.
İNANÇ, MEVLÜDE Et Al. "The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, 1878-1885, 2020
İNANÇ, MEVLÜDE Et Al. "The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, pp.1878-1885, 2020
İNANÇ, M. Et Al. (2020) . "The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, pp.1878-1885.
@article{article, author={MEVLÜDE İNANÇ Et Al. }, title={The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={1878-1885} }